Clinical Trial: A Study of Brenipatide in Participants With Alcohol Use Disorder

U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219953) titled 'A Study of Brenipatide in Participants With Alcohol Use Disorder' on Oct. 13.

Brief Summary: The purpose of this study is to see if brenipatide when compared to a placebo works and is safe for participants with Alcohol Use Disorder (AUD) and hazardous alcohol use. Participation in this study will last approximately 56 weeks.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Alcohol Use Disorder

Intervention: DRUG: LY3537031

Administered SC

DRUG: Placebo

Administered SC

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Eli Lilly and Company

Published by HT Digital Content Services with permission from Healt...